N-Acetylgalactosamine-6-Sulfatase
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-E70188-1MG | 1 mg | Inquire | ||
| HY-E70188-100uG | 100 µg | Inquire | ||
| HY-E70188-20uG | 20 µg | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
N-Acetylgalactosamine-6-Sulfatase (GALNS) is a potential general biomarker for multiple malignancies (such as lung cancer, breast cancer, head and neck cancer, etc.). N-Acetylgalactosamine-6-Sulfatase deficiency causes mucopolysaccharidosis type IVA (MPS IVA), also known as Morquio A syndrome. N-Acetylgalactosamine-6-Sulfatase can be used in MPS IVA as well as cancer research[1][2].
| Category | Enzyme/Substrate |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, s |
| Format | Solubility: 10 mM in DMSO |
| Grade | Clinical information: No Development Reported |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room temperature |
| Material Safety Data Sheet | Download PDF |
